BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 1428685)

  • 1. [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].
    Darius H; Erbel R; Belz GG; Meyer J
    Internist (Berl); 1992 Oct; 33(10):670-83. PubMed ID: 1428685
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
    Rühle H
    Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulants in heart disease.
    Vine DL
    Kans Med; 1991 Apr; 92(4):114, 112. PubMed ID: 1881021
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet inhibitors or anticoagulants in prevention after myocardial infarct? The 1991 state of the art].
    van de Loo J; Kienast J
    Z Gesamte Inn Med; 1992 Jan; 47(1):1-5. PubMed ID: 1570716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
    Gross R
    Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antithrombotic therapy in acute coronary syndrome].
    Chazov EI; Panchenko EP
    Ter Arkh; 2000; 72(3):65-75. PubMed ID: 10776658
    [No Abstract]   [Full Text] [Related]  

  • 9. [Summary: Secondary prophylaxis following myocardial re-infarct. Anticoagulants or thrombocyte function inhibitors?].
    Breddin K; Loeliger EA
    Internist (Berl); 1980 Jul; 21(7):399. PubMed ID: 7007281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drugs in interventional radiology. 2: Anticoagulation, thrombocyte aggregation inhibition, fibrinolysis].
    Hamer OW; Bollheimer LC; Feuerbach S; Strotzer M
    Radiologe; 2002 Jun; 42(6):489-98; quiz 499-501. PubMed ID: 12149911
    [No Abstract]   [Full Text] [Related]  

  • 11. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New thrombolytics, anticoagulants, and platelet antagonists: the future of clinical practice.
    Becker RC
    J Thromb Thrombolysis; 1999 Apr; 7(2):195-220. PubMed ID: 10364771
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
    Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis?
    Shah PK
    Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ; van Hattum ES
    Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current use of anti-hemostatics in ischemic cardiopathy].
    Bolao IG; Alegría E; Iglesias I; Velasco S; Fidalgo ML; Gómez JA; Huelmos A
    Rev Med Univ Navarra; 1990; 34(4):219-26. PubMed ID: 2152748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic agents and invasive procedures--hematologist point of view.
    Lecompte TP
    Thromb Res; 2012 Oct; 130 Suppl 1():S61-2. PubMed ID: 23026666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment strategies after successful thrombolysis in acute myocardial infarction.
    Ramsden CS
    Heart Lung; 1988 Nov; 17(6 Pt 2):777-82. PubMed ID: 2973449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.